Zelba, Henning, Weide, Benjamin, Martens, Alexander, Derhovanessian, Evelyna, Bailur, Jithendra Kini, Kyzirakos, Christina, Pflugfelder, Annette, Eigentler, Thomas K., Di Giacomo, Anna Maria, Maio, Michele, Aarntzen, Erik H.J.G., de Vries, Jolanda, Sucker, Antje, Schadendorf, Dirk, Büttner, Petra, Garbe, Claus, and Pawelec, Graham (2014) Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by Melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma. Clinical Cancer Research, 20 (16). pp. 4390-4399.

Weide, Benjamin, Martens, Alexander, Zelba, Henning, Stutz, Christina, Derhovanessian, Evelyna, Di Giacomo, Anna Maria, Maio, Michele, Sucker, Antje, Schilling, Bastian, Schadendorf, Dirk, Büttner, Petra, Garbe, Claus, and Pawelec, Graham (2014) Myeloid-rerived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1-or Melan-A-specific T cells. Clinical Cancer Research, 20 (6). pp. 1601-1609.